EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RRM2 Regulates Hepatocellular Carcinoma Progression Through Activation of TGF-β/Smad Signaling and Hepatitis B Virus Transcription

Dandan Wu, Xinning Sun, Xin Li, Zongchao Zuo, Dong Yan, Wu Yin

Genes · 06.12.2024 · 15 (12) · 1575

DOI: 10.3390/genes15121575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 06.12.2024. Verfasst von Dandan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Lab of Pharmaceutical Biotechnology (SKLPB), College of Life Sciences in Nanjing University (Xianlin Campus), Nanjing University, Nanjing 2…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ribonucleoside Diphosphate Reductase, Liver Neoplasms, Hepatitis B virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is a type of malignant tumor with high morbidity and mortality. Untimely treatment and high recurrence are currently the major challenges for HCC. The identification of potential targets of HCC progression is crucial for the development of new therapeutic strategies.

Methods

Bioinformatics analyses have been employed to discover genes that are differentially expressed in clinical cases of HCC. A variety of pharmacological methods, such as MTT, colony formation, EdU, Western blotting, Q-PCR, wound healing, Transwell, cytoskeleton F-actin filaments, immunohistochemistry (IHC), hematoxylin–eosin (HE) staining, and dual-luciferase reporter assay analyses, were utilized to study the pharmacological effects and potential mechanisms of ribonucleotide reductase regulatory subunit M2 (RRM2) in HCC.

Results

RRM2 expression is significantly elevated in HCC, which is well correlated with poor clinical outcomes. Both in vitro and in vivo experiments demonstrated that RRM2 promoted HCC cell growth and metastasis. Mechanistically, RRM2 modulates the EMT phenotype of HCC, and further studies have shown that RRM2 facilitates the activation of the TGF-β/Smad signaling pathway. SB431542, an inhibitor of TGF-β signaling, significantly inhibited RRM2-induced cell migration. Furthermore, RRM2 expression was correlated with diminished survival in HBV-associated HCC patients. RRM2 knockdown decreased the levels of HBV RNA, pgRNA, cccDNA, and HBV DNA in HepG2.2.15 cells exhibiting sustained HBV infection, while RRM2 knockdown inhibited the activity of the HBV Cp, Xp, and SpI promoters.

Conclusion

RRM2 is involved in the progression of HCC by activating the TGF-β/Smad signaling pathway. RRM2 increases HBV transcription in HBV-expressing HCC cells. Targeting RRM2 may be of potential value in the treatment of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularRibonucleoside Diphosphate ReductaseLiver NeoplasmsHepatitis B virusTransforming Growth Factor betaSignal TransductionGene Expression Regulation, NeoplasticSmad ProteinsHumansAnimalsMiceCell Line, TumorMaleCell ProliferationCell MovementTranscription, GeneticFemaleDisease ProgressionMice, Nude

Stichwörter der Autor:innen

HBVRRM2Smad2/3TGF-βhepatocellular carcinoma

Substanzen

Ribonucleoside Diphosphate Reductaseribonucleotide reductase M2Transforming Growth Factor betaSmad Proteins

Autor:innen und Institutionen

  • State Key Lab of Pharmaceutical Biotechnology (SKLPB), College of Life Sciences in Nanjing University (Xianlin Campus), Nanjing University, Nanjing 210046, China.
  • The First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
  • Department of Cardiology, Affiliated Hospital of Nanjing University of TCM, Nanjing 210023, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, D., Sun, X., Li, X., Zuo, Z., Yan, D., & Yin, W. (2024). RRM2 Regulates Hepatocellular Carcinoma Progression Through Activation of TGF-β/Smad Signaling and Hepatitis B Virus Transcription. Genes, 15(12), 1575. https://doi.org/10.3390/genes15121575

Vancouver

Wu D, Sun X, Li X, Zuo Z, Yan D, Yin W. RRM2 Regulates Hepatocellular Carcinoma Progression Through Activation of TGF-β/Smad Signaling and Hepatitis B Virus Transcription. Genes. 2024;15(12):1575. doi:10.3390/genes15121575

BibTeX
@article{Wu2024,
  author = {Wu, Dandan and Sun, Xinning and Li, Xin and Zuo, Zongchao and Yan, Dong and Yin, Wu},
  title = {RRM2 Regulates Hepatocellular Carcinoma Progression Through Activation of TGF-β/Smad Signaling and Hepatitis B Virus Transcription},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {12},
  pages = {1575},
  doi = {10.3390/genes15121575}
}
Kostenlos starten →